DrugsControl Media Services

News Detail

Cancer Drug Resistance Predicted by CRISPR Screens (11-05-2018)

London, 10 May 2018: Scientists at the Institute of Cancer Research (ICR) in the U.K. have harnessed CRISPR-Cas9 genome-editing technology to uncover why some tumors are resistant to poly(ADP-ribose) polymerase  inhibitors (PARPi), such as olaparib and ta......
View Details

Source : Genetic Engineering & Biotechnology News

Related News